From: Detection methods predict differences in biology and survival in breast cancer patients
False Negative mammograms (n = 20) vs. Incident (n = 65) | P value | OR | |
---|---|---|---|
Mean age | 60.8 + 1.1 vs. 59.7 + 0.6 | N.S. | 1.04 (0.93-1.15) |
Mean size (cm) | 1.17 + 0.16 vs. 1.27 + 0.09 | N.S. | 0.79 (0.34-1.86) |
Lymph node positive | 6.3% vs. 21.5% | N.S. | 0.24 (0.02-2.00) |
Poorly differentiated tumors | 50% vs. 40% | N.S. | 1.50 (0.50-4.49) |
ER positive | 95% vs. 89% | N.S. | 1.59 (0.17-14.4) |
PR positive | 85.7% vs. 78.2% | N.S. | 1.67 (0.32-8.52) |
In situ carcinomas | 6.3% vs. 11% | N.S. | 0.55 (0.06-4.84) |
Apoptosis | 42.9% vs. 66.7% | N.S. | 0.37 (0.06-2.15) |
Bcl-2 | 84.6% vs. 81.3% | N.S. | 1.26 (0.23-6.75) |
c-erb-B2 | 15% vs. 23.1% | N.S. | 0.41 (0.04-3.79) |
Ki67 | 33.3% vs. 63% | p < 0.05 | 0.29 (0.08-0.98) |
Delay Diag- treat (>30 days) | 37.9% vs. 35.4% | N.S. | 1.09 (0.33-3.59) |